全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1266115-22-3 | 3-Iodo-1-isopropyl-1H-pyrazole | C6H9IN2 |
| 1266158-02-4 | 4-(1-Aminocyclopropyl)phenol | C9H11NO |
| 1266212-81-0 | A-887826 | C26H29ClN4O3 |
| 1266238-63-4 | Ethyl 2,6-dichloro-5-fluoropyrimidine-4-carboxylate | C7H5Cl2FN2O2 |
| 1266339-10-9 | tert-butyl (3R)-3-fluoro-4-oxopiperidine-1-carboxylate | C10H16FNO3 |
| 1266343-30-9 | 5-Bromo-4-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | C7H5BrClN3 |
| 1266350-99-5 | (4S,5R)-3-[(2S)-3-(1,1-Dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2,5-trimethyl-4-oxazolidinecarboxylic acid | C29H36N2O7 |
| 1266615-59-1 | 4-Morpholineethanesulfonic acid hydrate (1:?) | C6H13NO4S.x(H2O) |
| 1266620-74-9 | Montelukast Sulfone;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfonylmethyl]cyclopropyl]acetic acid | C35H36ClNO5S |
| 1266659-06-6 | 1-(5-Fluoro-2-nitrophenyl)-2-propanone | C9H8FNO3 |
| 1266663-89-1 | Oseltamivir Impurity 11;(1R,5R,6R)-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester | C14H22O4 |
| 1266664-66-7 | 5-Chloro-2-((R)-5-methyl-[1,4]diazepan-1-yl)benzooxazole hydrochloride | C13H16ClN3O.HCl |
| 1266666-04-9 | N6-[(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-6-yl)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine | C42H34N2O10 |
| 1266688-86-1 | 2-(Ethylamino)-1-(4-methylphenyl)-1-propanone hydrochloride;rac-N-Ethyl-4-methylcathinone hydrochloride | C12H17NO.HCl |
| 1266975-27-2 | 5-Chloro-2-[(5R)-hexahydro-5-methyl-1H-1,4-diazepin-1-yl]benzoxazole | C13H16ClN3O |
| 1267217-46-8 | 5-(Trifluoromethyl)benzoxazole | C8H4F3NO |
| 1267467-45-7 | 3-bromo-5-chloro-N-methylpyridin-2-amine | C6H6BrClN2 |
| 1267540-02-2 | 2,5-Bis(2-octyldodecyl)-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione | C54H88N2O2S2 |
| 1267610-26-3 | 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone | C15H19N3O2 |
| 1268140-15-3 | 5,7,3'-Trihydroxy-4'-methoxy-8-prenylflavanone;(2S)-2,3-Dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one | C21H22O6 |
| 1268454-23-4 | [6-(2-Amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinylmethanone | C19H17N5O3 |
| 1268467-17-9 | 2-(2,2,2-Trifluoroethoxy)pyridine-5-boronic acid pinacol ester;5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethoxy)pyridine | C13H17BF3NO3 |
| 1268475-20-2 | (2S,3R)-2-Methyl-3-morpholinecarboxylic acid | C6H11NO3 |
| 1268519-74-9 | 2-Amino-9,9-diphenylfluorene;9,9-Diphenyl-9H-fluoren-2-amine | C25H19N |
| 1268520-04-2 | Biphenyl-4-yl(9,9-diphenyl-9H-fluoren-2-yl)amine;N-[1,1'-Biphenyl]-4-yl-9,9-diphenyl-9H-fluoren-2-amine | C37H27N |
| 1268520-05-3 | (3R,4R)-rel-4-Amino-3-fluoro-1-piperidinecarboxylic acid phenylmethyl ester | C13H17FN2O2 |
| 1268520-93-9 | (3-Fluoroazetidin-3-YL)methanol | C4H8FNO |
| 1268520-95-1 | rel-N-[(3R,4R)-3-Fluoro-4-piperidinyl]carbamic acid 1,1-dimethylethyl ester;tert-Butyl (trans)-3-fluoropiperidin-4-ylcarbamate | C10H19FN2O2 |
| 1268521-35-2 | cis-3-Methoxy-cyclobutanamine | C5H11NO |
| 1268521-83-0 | tert-Butyl (cis)-3-fluoropiperidin-4-ylcarbamate | C10H19FN2O2 |
| 1268521-85-2 | 3-Hydroxycyclobutanecarboxylic acid | C5H8O3 |
| 1268524-70-4 | (+)-JQ-1;(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate | C23H25ClN4O2S |
| 1268524-71-5 | (-)-JQ-1;(R)-(-)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate | C23H25ClN4O2S |
| 1268810-07-6 | 1-[2-(Trimethylsilyl)ethynyl]cyclopropanecarboxylic acid | C9H14O2Si |
| 1268810-09-8 | N-(1-Ethynylcyclopropyl)carbamic acid 1,1-dimethylethyl ester | C10H15NO2 |
| 1268810-13-4 | (Cyclobutylethynyl)trimethylsilane;[2-(Trimethylsilyl)ethynyl]cyclobutane; (Cyclobutylethynyl)trimethylsilane | C9H16Si |
| 1268810-17-8 | 1-Ethynylcyclopropanamine hydrochloride (1:1) | C5H7N.HCl |
| 1268836-55-0 | 2-[[6-[(3R)-3-[[3-[(2-Cyanophenyl)methyl]-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]amino]-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile | C31H30N8O4 |
| 1269004-46-7 | 2,5-Bis(2-ethylhexyl)-2,5-dihydro-3,6-bis[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thienyl]pyrrolo[3,4-c]pyrrole-1,4-dione | C42H62B2N2O6S2 |
| 1269232-96-3 | 5-Chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenamine | C12H16BClFNO2 |
| 1269266-69-4 | 5,8-Dibromo-11H-benzo[a]carbazole | C16H9Br2N |
| 1269292-88-7 | 4-Bromo-N-cyclohexyl-2-pyrimidinamine | C10H14BrN3 |
| 1269293-48-2 | Ethyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate | C7H9BrN2O2 |
| 1269440-17-6 | Encorafenib;LGX 818; methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate | C22H27ClFN7O4S |
| 1269440-69-8 | N-[5-Chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamic acid 1,1-dimethylethyl ester;tert-butyl N-[5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate | C17H24BClFNO4 |
| 1269483-57-9 | (3R)-3-Morpholinecarboxylic acid ethyl ester hydrochloride (1:1) | C7H13NO3.HCl |
| 1269493-45-9 | 5-Bromo-2-fluoro-4-methylbenzonitrile | C8H5BrFN |
| 1269755-11-4 | (3R,4S)-1-((Benzyloxy)carbonyl)-4-fluoropyrrolidine-3-carboxylic acid | C13H14FNO4 |
| 1269755-53-4 | 5-(Trifluoromethyl)-3-piperidinecarboxylic acid methyl ester | C8H12F3NO2 |
| 1269815-17-9 | Novartis;(3R)-N-[5-Chloro-4-(5-fluoro-2-methoxyphenyl)-2-pyridinyl]-3-piperidinecarboxamide | C18H19ClFN3O2 |